Tetrandrine inhibits hepatocellular carcinoma cell growth through the caspase pathway and G2/M phase.

Abstract:

:Activation of p53-independent pathways plays an important role in phytochemical-induced apoptosis and is considered to be a crucial factor in the invasion and metastasis of cancer. Previous studies have shown that combined effects of Stephania tetrandra with medicinal herbs exhibit beneficial effects in cancer patients. Tetrandrine, an active component of Stephania tetrandra has been reported to have anticancer properties in cancer cells. However, the mechanism(s) of action of tetrandrine in liver cancer have yet to be fully elucidated. In this study, we investigated the effects of tetrandrine in hepatocellular carcinoma (HCC) cells. The results showed that tetrandrine inhibited HCC cell proliferation by suppression of cell cycle progression at the G2/M phase. Changes in the expression levels of Bax, Bcl, p53, survivin, PCNA, PARP and p21 were observed. In addition, tetrandrine increased caspase-3 expression and induced DNA fragmentation in Huh-7 cells. The results suggest that the anti-cancer effect of tetrandrine in Huh-7 cells may be mediated by p53-independent pathways.

journal_name

Oncol Rep

journal_title

Oncology reports

authors

Yu VW,Ho WS

doi

10.3892/or.2013.2352

subject

Has Abstract

pub_date

2013-06-01 00:00:00

pages

2205-10

issue

6

eissn

1021-335X

issn

1791-2431

journal_volume

29

pub_type

杂志文章